HSBC Upgrades Synopsys to Buy and Raises Price Target to $700

Summary

HSBC upgraded Synopsys (SNPS) to 'Buy' with a $700 target price, citing strong Q3 results, a shift toward a royalty-based model, and surging demand for Agentic AI. The upgrade follows a quarter where revenue hit $2.48B and EPS reached $2.84, significantly beating expectations benzinga_articleST/US/SNPS.

Impact Analysis

HSBC isn't just bumping a target here; they’re setting a new ceiling for the stock at $700. The interesting part isn't just the Q3 beat—though an 82.5% gross margin is impressive ST/US/SNPS—it’s the narrative shift. So basically, they’re arguing that the market has been too defensive regarding the Ansys acquisition and China risks benzinga_articleST/US/SNPS.

I’d read this as a signal that Synopsys is successfully transitioning from a cyclical EDA provider into a mission-critical AI platform. The 'Agentic AI' demand is the real kicker; as chip complexity explodes, Synopsys’s tools become the bottleneck for the entire industry. HSBC’s FY27 EPS estimate of $20.01 is 13% above consensus, suggesting they see a massive earnings power unlock that the Street is still sleeping on benzinga_article. If you believe the AI hardware race has legs, SNPS is the 'toll booth' you want to own. The risk remains the heavy lifting of Ansys integration, but at 35x forward earnings, the risk/reward is starting to look very attractive.